Ledger.Open graph →
SEC Form D · filed January 10, 2014

SALIX PHARMACEUTICALS LTD

Offering
$750.0M
Sold
$750.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Raleigh, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Mark A. Sirgo · Raleigh, NCDirectorRick D. Scruggs · Raleigh, NCExecThomas W. D'Alonzo · Raleigh, NCDirectorWilliam P. Forbes · Raleigh, NCExecJohn F. Chappell · Raleigh, NCDirectorWilliam P. Keane · Raleigh, NCDirectorCarolyn J. Logan · Raleigh, NCExec · DirectorAdam C. Derbyshire · Raleigh, NCExecAdam C. Derbyshire · Raleigh, NCExecThomas W. D'Alonzo · Raleigh, NCDirectorWilliam P. Forbes · Raleigh, NCExecJohn F. Chappell · Raleigh, NCDirectorMark A. Sirgo · Raleigh, NCDirectorWilliam P. Keane · Raleigh, NCDirectorCarolyn J. Logan · Raleigh, NCExec · DirectorRick D. Scruggs · Raleigh, NCExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗